Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

741
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
741
Inflammatory Response01:28

Inflammatory Response

1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
T Cell Types and Functions01:24

T Cell Types and Functions

946
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
946
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The cholesterol-dependent cytolysin promotes <i>Streptococcus</i> systemic spread and induces arachidonic acid accumulation-mediated lethality in a murine intraperitoneal infection model.

Infection and immunity·2026
Same author

IL-22 promotes genesis of small intestinal secretory cells that protect against cholera in mice.

Nature microbiology·2026
Same author

Early-life Wnt4 expressing colon stromal cells orchestrate lifelong mucosal homeostasis via BMP-driven iNKT cell imprinting.

Nature communications·2026
Same author

A diagnostic challenge of advanced-stage cardiac Fabry disease without left ventricular hypertrophy: a case report.

European heart journal. Case reports·2026
Same author

A pro-carcinogenic bacterial toxin binds claudin-4 to cleave E-cadherin.

Nature·2026
Same author

IL-22 promotes genesis of small intestinal secretory cells that protect against cholera in mice.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 2, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

344

Reverse transcriptase inhibitors diminish systemic proinflammatory responses to bacterial pathogens.

Karthik Hullahalli1,2, Katherine G Dailey1,2, Ryan Acbay1,2

  • 1Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.

Mbio
|January 14, 2025
PubMed
Summary
This summary is machine-generated.

Nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) significantly reduce damaging inflammation during bacterial infections. These NRTIs also protect against lethal sepsis by dampening systemic immune overreactions, offering potential new therapeutic avenues.

Keywords:
inflammationreverse transcriptase inhibitorssepsis

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

7.8K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K

Related Experiment Videos

Last Updated: Jun 2, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

344
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

7.8K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K

Area of Science:

  • Immunology
  • Microbiology
  • Pharmacology

Background:

  • Bacterial infections can trigger excessive immune responses, leading to host tissue damage, such as liver necrosis observed in *Escherichia coli* infections.
  • Endogenous retroviruses and their encoded reverse transcriptase activity have been implicated in mediating tissue damage during systemic infections.
  • Nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) previously showed potential in preventing tissue damage and bacterial growth in infected lesions.

Purpose of the Study:

  • To investigate the hypothesis that NRTIs can diminish inflammation caused by bacterial infections.
  • To explore the broader impact of NRTIs on the systemic innate immune response to bacterial pathogens.
  • To assess the therapeutic potential of NRTIs in models of bacterial infection and sepsis.

Main Methods:

  • Mice were inoculated with *Escherichia coli*, and the effects of NRTI administration on liver inflammation and systemic immune markers were characterized.
  • The study evaluated NRTI efficacy in response to other bacterial challenges, including lipopolysaccharide (LPS) and *Staphylococcus aureus*.
  • A lethal LPS shock model was used to assess NRTI's protective effects against mortality and hypothermia.

Main Results:

  • NRTI administration significantly reduced the expression of proinflammatory transcripts in the liver following *E. coli* infection.
  • NRTIs demonstrated systemic anti-inflammatory effects, lowering serum proinflammatory cytokine levels in response to *E. coli* across different mouse strains.
  • NRTI treatment protected mice from hypothermia and death in a lethal LPS shock model, indicating broad efficacy against Gram-positive and Gram-negative bacterial infections.

Conclusions:

  • NRTIs potently inhibit systemic inflammatory responses during bacterial infections, suggesting a novel therapeutic role beyond retroviral infections.
  • The findings highlight the potential of targeting reverse transcriptase activity to control excessive inflammation and prevent tissue damage in infectious diseases.
  • Further research into the mechanisms of NRTI anti-inflammatory action is warranted for developing new treatments for non-retroviral infectious diseases and sepsis.